# Nat Imm成年人数据分析(不建议使用)

## 0 分析之前

Nat Imm中大部分人都是儿童患者/对照，而我们知道儿童的免疫系统本来就和成年人有较大区别。为了控制变量，先只分析了文章中的成年人队列，一共14个人，6位健康对照，8位SLE患者，均为女性，年龄分布在24-63岁，文章中提供的meta如下

| Names                          | Groups | Batch | Age  | Gender | Race         | Ethnicity    | SLEDAI | Physician Notes | Collection_year | Symptoms | MDG  | Arthritis | Rash | Proteinuria | Hematuria | Urinary Casts | Pyuria | dsDNA | low_com | fever | pleurisy | vasculitis | Alopecia | Leukopenia | MMF  | OS   | MTX  | Plaquenil | Neph_all | Proliferative_Neph | Memb_Neph | Nephrology_Class | Neph_class | ESR  | WBC  | RBC  | MONOCYTE_per | NEUTROPHIL_per | LYMPHOCYTE_per | HGB  | HCT  | PLATELETS | NEU_ABS | LYM_ABS | CREATININE | ALBUMIN | DSDNA_ratio | DSDNA | C3   | C4   | ALT  | AST  | ALD  | LDH  | MSK  | KIDNEY | SERUM |
| ------------------------------ | ------ | ----- | ---- | ------ | ------------ | ------------ | ------ | --------------- | --------------- | -------- | ---- | --------- | ---- | ----------- | --------- | ------------- | ------ | ----- | ------- | ----- | -------- | ---------- | -------- | ---------- | ---- | ---- | ---- | --------- | -------- | ------------------ | --------- | ---------------- | ---------- | ---- | ---- | ---- | ------------ | -------------- | -------------- | ---- | ---- | --------- | ------- | ------- | ---------- | ------- | ----------- | ----- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ------ | ----- |
| aHD1                           | aHD    | B1    | 39   | F      | AA           | NH           | ND     | NA              | 2018            | NA       | ND   | ND        | ND   | ND          | ND        | ND            | ND     | ND    | ND      | ND    | ND       | ND         | ND       | ND         | ND   | ND   | ND   | ND        | ND       | ND                 | ND        | ND               | ND         | ND   | ND   | ND   | ND           | ND             | ND             | ND   | ND   | ND        | ND      | ND      | ND         | ND      | ND          | ND    | ND   | ND   | ND   | ND   | ND   | ND   | ND   | ND     | ND    |
| <font color = RED>aHD2</font>  | aHD    | B1    | 50   | F      | C            | NH           | ND     | NA              | 2018            | NA       | ND   | ND        | ND   | ND          | ND        | ND            | ND     | ND    | ND      | ND    | ND       | ND         | ND       | ND         | ND   | ND   | ND   | ND        | ND       | ND                 | ND        | ND               | ND         | ND   | ND   | ND   | ND           | ND             | ND             | ND   | ND   | ND        | ND      | ND      | ND         | ND      | ND          | ND    | ND   | ND   | ND   | ND   | ND   | ND   | ND   | ND     | ND    |
| aHD3                           | aHD    | B1    | 43   | F      | H            | H            | ND     | NA              | 2018            | NA       | ND   | ND        | ND   | ND          | ND        | ND            | ND     | ND    | ND      | ND    | ND       | ND         | ND       | ND         | ND   | ND   | ND   | ND        | ND       | ND                 | ND        | ND               | ND         | ND   | ND   | ND   | ND           | ND             | ND             | ND   | ND   | ND        | ND      | ND      | ND         | ND      | ND          | ND    | ND   | ND   | ND   | ND   | ND   | ND   | ND   | ND     | ND    |
| aHD4                           | aHD    | B2    | 36   | F      | H            | H            | ND     | NA              | 2018            | NA       | ND   | ND        | ND   | ND          | ND        | ND            | ND     | ND    | ND      | ND    | ND       | ND         | ND       | ND         | ND   | ND   | ND   | ND        | ND       | ND                 | ND        | ND               | ND         | ND   | ND   | ND   | ND           | ND             | ND             | ND   | ND   | ND        | ND      | ND      | ND         | ND      | ND          | ND    | ND   | ND   | ND   | ND   | ND   | ND   | ND   | ND     | ND    |
| aHD5                           | aHD    | B2    | 46   | F      | C            | NH           | ND     | NA              | 2018            | NA       | ND   | ND        | ND   | ND          | ND        | ND            | ND     | ND    | ND      | ND    | ND       | ND         | ND       | ND         | ND   | ND   | ND   | ND        | ND       | ND                 | ND        | ND               | ND         | ND   | ND   | ND   | ND           | ND             | ND             | ND   | ND   | ND        | ND      | ND      | ND         | ND      | ND          | ND    | ND   | ND   | ND   | ND   | ND   | ND   | ND   | ND     | ND    |
| aHD6                           | aHD    | B2    | 47   | F      | AA           | NH           | ND     | NA              | 2018            | NA       | ND   | ND        | ND   | ND          | ND        | ND            | ND     | ND    | ND      | ND    | ND       | ND         | ND       | ND         | ND   | ND   | ND   | ND        | ND       | ND                 | ND        | ND               | ND         | ND   | ND   | ND   | ND           | ND             | ND             | ND   | ND   | ND        | ND      | ND      | ND         | ND      | ND          | ND    | ND   | ND   | ND   | ND   | ND   | ND   | ND   | ND     | ND    |
| aSLE1                          | aSLE   | B1    | 37   | F      | AA           | NH           | 15     | NA              | 2018            | NA       | ND   | 0         | 0    | 4           | 0         | 0             | 0      | 2     | 0       | 0     | 0        | 8          | 0        | 1          | 0    | 0    | 1    | 1         | 1        | ND                 | ND        | ND               | ND         | 27   | 2.4  | 5.19 | 12.4         | 46.6           | 39             | 14.8 | 47.7 | 148       | 1.1     | 0.9     | 0.9        | 4.3     | ND          | 88    | 124  | 36   | 16   | 26   | ND   | ND   | 0    | 1      | 1     |
| aSLE2                          | aSLE   | B1    | 63   | F      | not reported | H            | 14     | NA              | 2018            | NA       | ND   | 0         | 0    | 4           | 4         | 0             | 4      | 2     | 0       | 0     | 0        | 0          | 0        | 0          | 0    | 1    | 0    | 1         | 0        | ND                 | ND        | ND               | ND         | 23   | 3.8  | 3.91 | 5.8          | 88.5           | 3.7            | 12   | 37.3 | 136       | 3.4     | 0.1     | 0.7        | 3.7     | ND          | 891   | ND   | ND   | 11   | 13   | ND   | ND   | 0    | 1      | 1     |
| aSLE3                          | aSLE   | B1    | 36   | F      | C            | not reported | 0      | NA              | 2018            | NA       | ND   | 0         | 0    | 0           | 0         | 0             | 0      | 0     | 0       | 0     | 0        | 0          | 0        | 0          | 0    | 0    | 0    | 0         | 1        | ND                 | ND        | ND               | ND         | 12   | 7.3  | 3.78 | 7.7          | 70.8           | 19.2           | 11.1 | 34.1 | 248       | 5.2     | 1.4     | 1          | 4.3     | 1\320       | 15    | 104  | 23   | <6   | 14   | ND   | ND   | 0    | 0      | 0     |
| aSLE4                          | aSLE   | B1    | 58   | F      | not reported | H            | 2      | NA              | 2018            | NA       | ND   | 0         | 0    | 0           | 0         | 0             | 0      | 2     | 0       | 0     | 0        | 0          | 0        | 0          | 1    | 1    | 0    | 1         | 0        | ND                 | ND        | ND               | ND         | 26   | 11.5 | 4.42 | 6.7          | 79.8           | 11.8           | 13.2 | 42.1 | 256       | 9.2     | 1.4     | 0.8        | 4.3     | 1\640       | 430   | 131  | 20   | 18   | 22   | ND   | ND   | 0    | 0      | 1     |
| aSLE5                          | aSLE   | B2    | 24   | F      | H            | H            | 2      | NA              | 2018            | NA       | ND   | 0         | 2    | 0           | 0         | 0             | 0      | 0     | 0       | 0     | 0        | 0          | 0        | 0          | 0    | 1    | 0    | 1         | 0        | ND                 | ND        | ND               | ND         | 12   | 3.7  | 4.3  | 8            | 48.2           | 39.9           | 12.4 | 38.2 | 185       | 1.8     | 1.5     | 0.7        | 4.7     | ND          | 13    | 122  | 21   | 15   | 19   | ND   | ND   | 1    | 0      | 0     |
| aSLE6                          | aSLE   | B2    | 27   | F      | H            | H            | 4      | NA              | 2018            | NA       | ND   | 0         | 2    | 0           | 0         | 0             | 0      | 0     | 0       | 0     | 0        | 0          | 2        | 0          | 0    | 1    | 0    | 0         | 0        | ND                 | ND        | ND               | ND         | 21   | 8.8  | 4.87 | 9.8          | 66.9           | 20.3           | 13.2 | 41.9 | 318       | 5.9     | 1.8     | 0.6        | ND      | 1\5120      | 14    | 82   | 19   | 7    | 16   | ND   | ND   | 1    | 0      | 0     |
| aSLE7                          | aSLE   | B2    | 47   | F      | C            | NH           | 6      | NA              | 2018            | NA       | ND   | 4         | 2    | 0           | 0         | 0             | 0      | 0     | 0       | 0     | 0        | 0          | 0        | 0          | 0    | 0    | 0    | 1         | 0        | ND                 | ND        | ND               | ND         | 92   | 8.3  | 4.85 | 10.5         | 62             | 25.7           | 9.6  | 33.1 | 470       | 5.1     | 2.1     | 0.9        | 4.5     | ND          | 11    | 169  | 20   | 10   | 13   | ND   | ND   | 1    | 0      | 0     |
| <font color = RED>aSLE8</font> | aSLE   | B2    | 62   | F      | AA           | NH           | 2      | NA              | 2018            | NA       | ND   | 0         | 0    | 0           | 0         | 0             | 0      | 2     | 0       | 0     | 0        | 0          | 0        | 0          | 0    | 1    | 0    | 1         | 0        | ND                 | ND        | ND               | ND         | 52   | 4    | 4.89 | 12.9         | 52             | 32.2           | 13.9 | 43   | 311       | 2.1     | 1.3     | 0.9        | 4.5     | 1\1280      | 68    | 175  | 33   | 17   | 21   | ND   | ND   | 0    | 0      | 1     |

实际在作者公布的数据中只有7个SLE和5个对照（未提供样本的在表中标红），每个样本的细胞数量如下，SLE的患者的细胞

```shell
       aHD1  aHD3  aHD4  aHD5  aHD6 aSLE1 aSLE2 aSLE3 aSLE4 aSLE5 aSLE6 aSLE7
  HD   7179  7174  6606  8116 12249     0     0     0     0     0     0     0
  SLE     0     0     0     0     0  4298  4505  7442  6193  4578  3725  4543
```

## 1 全PBMC分析

这批数据对批次效应控制较好，在作者声明的两个Batch中，未出现明显的batch effect效应。

![image-20210410191014267](https://gitee.com/huhansan666666/picture/raw/master/img/image-20210410191014267.png)

对于主要细胞类型的注释如下：

![image-20210410191120163](https://gitee.com/huhansan666666/picture/raw/master/img/image-20210410191120163.png)



同时发现了他们数据中的一些质量问题：

1. 没有免疫球蛋白相关基因，按理来说10x cellranger的结果肯定是有相关基因的，最可能的解释是作者有意删除了，拿到原始数据之后重新运行上游步骤就清楚了

2. 不同患者测序数目不平衡，可以明显发现，大部分SLE病人所测序的细胞数量要低于健康对照

   ![image-20210410191334295](https://gitee.com/huhansan666666/picture/raw/master/img/image-20210410191334295.png)

3. 数据质量不高，有一定比例的红细胞，这说明PBMC解离的步骤不标准，并且在一些样本（如下图）的各个细胞类型中都检测到了红细胞marker gene的表达，可能是mRNA污染。在1，2，7这3个SLE患者样本中这个现象尤其严重
   ![image-20210409190608228](https://gitee.com/huhansan666666/picture/raw/master/img/image-20210409190608228.png)

## 2 B cell

B cell在SLE和患者中分布差异不大，并且没有发现和我们自己数据中表达多种细胞marker的细胞，也没有发现TLB_plasma（abnormal），但是发现了TLB_mem1和TLB_mem2

![image-20210410191838851](https://gitee.com/huhansan666666/picture/raw/master/img/image-20210410193323318.png)![image-20210410193457917](https://gitee.com/huhansan666666/picture/raw/master/img/image-20210410193457917.png)![image-20210410193554273](https://gitee.com/huhansan666666/picture/raw/master/img/image-20210410193554273.png)

但是可能是这个数据集质量的问题，背景有点高，体现在B cell发现其他细胞marker也有 星星点点的表达，

![image-20210410192124155](https://gitee.com/huhansan666666/picture/raw/master/img/image-20210410192124155.png)

干扰素相关基因在部分患者中有高表达,提示不能忽略了患者之间的异质性

![image-20210410194305108](https://gitee.com/huhansan666666/picture/raw/master/img/image-20210410194305108.png)

此外，在这一组**成年人**的B cell中没有发现CD11C+ B cell，但是文章在child SLE队列中报道了，在我们的数据中也发现了。CD11C+ B cell被认为可能是在生发中心之外成熟，因而可能与自身免疫有较强的关系。

## 3 pDC

pDC中出现了更加明显“混合marker”表达的细胞，尤其是cluster3，但是pDC的总数很小，8个病人只有372个细胞，可能随机因素比较大一点。

需要注意的是，这里“混合marker”表达的细胞的UMI和Gene的数量并没有显著小于正常细胞，反而比正常的pDC要更高，暂时无法解释

![image-20210410201334791](https://gitee.com/huhansan666666/picture/raw/master/img/image-20210410201334791.png)

![image-20210410202247039](https://gitee.com/huhansan666666/picture/raw/master/img/image-20210410202247039.png)



## 4 platelet

有趣的是在platelet中观察到了T cell marker（cluster 1，4，7 ）以及macrophage marker（0，2，5）同时表达的情况，当然也有正常的platelet（cluster3，6）

![image-20210410203254421](https://gitee.com/huhansan666666/picture/raw/master/img/image-20210410203254421.png)

![image-20210410202628390](https://gitee.com/huhansan666666/picture/raw/master/img/image-20210410202628390.png)



![image-20210410203410612](https://gitee.com/huhansan666666/picture/raw/master/img/image-20210410203410612.png)

![image-20210410203432204](https://gitee.com/huhansan666666/picture/raw/master/img/image-20210410203432204.png)

![image-20210410203507551](https://gitee.com/huhansan666666/picture/raw/master/img/image-20210410203507551.png)



## 5 Macro and cDC

发现混杂表达T cell 和macrophage marker的细胞，但是这类细胞（标记为macro_t）并没有UMI和Gene的显著下降，而是在正常的区间范围

![image-20210411103333136](https://gitee.com/huhansan666666/picture/raw/master/img/image-20210411103333136.png)

![image-20210411103550089](https://gitee.com/huhansan666666/picture/raw/master/img/image-20210411103550089.png)



## 6 T cell

被红细胞的基因污染，在想解决的办法



## 7 NK 

NK细胞按照疾病状态和患者来源如下，发现个体异质性比较大，

<img src="https://gitee.com/huhansan666666/picture/raw/master/img/image-20210410185425217.png" alt="image-20210410185425217" style="zoom:80%;" /><img src="https://gitee.com/huhansan666666/picture/raw/master/img/image-20210410185512326.png" alt="image-20210410185512326" style="zoom:80%;" />



## 8 其他发现

TLB细胞与macro_t之间的可能区别，张泽民老师在发表在Cell上的髓样细胞图谱的工作中也报道过一些macrophage细胞表达T cellmaker，他们认为是doublet直接扔掉 了。但是他们在之前遇到同时表达T cell和 B cell marker 的细胞的时候引用了 [T1D 的文献](https://www.cell.com/cell/abstract/S0092-8674(19)30505-7)，而没有直接说是doublet。虽然不知道张老师组如何定义doublet，但是他们肯定有深入调研过这类表达混合marker细胞。

利用singleR从全转录组相似度的角度看，TLB比macro_t在两种细胞类型之间的得分更加平均。简单的说，TLB像是T cell和B cell等比例的融合，而macro_t像是非等比例的融合

**![image-20210411110542196](https://gitee.com/huhansan666666/picture/raw/master/img/image-20210411110542196.png)**

## 9 总结

以上结论仅供参考，我总感觉数据有点奇怪，并且作者貌似删除了IG（免疫球蛋白）相关的基因，不敢确认目前发现的生物学的现象的真实性。

建议等丁阳师兄的原始数据，我们重新从cellranger的步骤分析